H.L.Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.40 Cr
as on 17-07-2024
- Paid Up Capital ₹ 1.40 Cr
as on 17-07-2024
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.32 Cr
as on 17-07-2024
- Satisfied Charges ₹ 0.73 Cr
as on 17-07-2024
- Revenue 3.66%
(FY 2023)
- Profit 14.74%
(FY 2023)
- Ebitda 67.85%
(FY 2023)
- Net Worth 30.06%
(FY 2023)
- Total Assets 66.77%
(FY 2023)
About H.L.Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.40 Cr and a paid-up capital of Rs 1.40 Cr.
The company currently has active open charges totaling ₹3.32 Cr. The company has closed loans amounting to ₹7.26 M, as per Ministry of Corporate Affairs (MCA) records.
Lakhwinder Arora and Aveen Arora serve as directors at the Company.
- CIN/LLPIN
U24230PB2005PTC028100
- Company No.
028100
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Mar 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Jalandhar, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does H.L.Healthcare Private Limited offer?
H.L.Healthcare Private Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Allopathic Cough Syrup, Anti Infective Drugs & Medicines, Antiparasitic Drug, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs, Ayurvedic,Herbal Products & Medicine, Herbal Capsules, Antifungal Injection, Tablet & Syrup.
Who are the key members and board of directors at H.L.Healthcare?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Lakhwinder Arora | Director | 14-Mar-2005 | Current |
Aveen Arora | Director | Current |
Financial Performance and Corporate Structure Insights of H.L.Healthcare.
H.L.Healthcare Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.66% increase. The company also saw a substantial improvement in profitability, with a 14.74% increase in profit. The company's net worth Soared by an impressive increase of 30.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of H.L.Healthcare?
In 2023, H.L.Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
State Bank Of India Creation Date: 13 Feb 2007 | ₹3.32 Cr | Open |
State Bank Of Patiala Creation Date: 28 Feb 2013 | ₹1.40 M | Satisfied |
General Manager Creation Date: 07 May 2011 | ₹1.36 M | Satisfied |
How Many Employees Work at H.L.Healthcare?
Unlock and access historical data on people associated with H.L.Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Aug 04, 2023, H.L.Healthcare has raised a total of ₹ 1.46 Cr, with the most recent deal valued at ₹ 2.47 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.